역시 젤 좋은 비지니스는 모델은 독점이지요. 라이벌 회사를 사서 가격을 올리면 수익을 올라갈수 밖에 없겠지요. 그것이 건강과 생명과 연결된 약이라면 수요는 일정하고 가격저항은 적으니 더 당연하겠지요. 좋은 사회일수록 이런식으로 소비자의 이익이 훼손되는 것을 막을수 있어야 겠죠. 내돈가지고 내 맘대로 하는게 많은 국민의 이익과 배치된다면 막아야합니다.
----------------------
http://www.wsj.com/articles/pharmaceutical-companies-buy-rivals-drugs-then-jack-up-the-prices-1430096431
Pharmaceutical Companies Buy Rivals’ Drugs, Then Jack Up the Prices
List prices soar on Valeant’s heart medications and other firm’s drugs, driving up costs
On Feb. 10, Valeant Pharmaceuticals International Inc. bought the rights to a pair of life-saving heart drugs. The same day, their list prices rose by 525% and 212%.
Neither of the drugs, Nitropress or Isuprel, was improved as a result of costly investment in lab work and human testing, Valeant said. Nor was manufacture of the medicines shifted to an expensive new plant. The big change: the drugs’ ownership.
“Our duty is to our shareholders and to maximize the value” of the products that Valeant sells, said Laurie Little, a company spokeswoman. “Sometimes pricing comes into it, sometimes volume comes into it.”
More pharmaceutical companies are buying drugs that they see as undervalued, then raising the prices. It is one of a number of industry tactics, along with companies regularly upping the prices of their own older medicines and launching new treatments at once unheard of sums, driving up the cost of drugs.
Since 2008, branded-drug prices have increased 127%, compared with an 11% rise in the consumer price index, according to drug-benefits manager Express Scripts Holding Co. Needham & Co. said in a June 2014 research note there were as many as 50% drug-price increases during the previous 2½ years as there were in the prior decade.
...
'경제이야기 > 통계,그래프' 카테고리의 다른 글
| 대한민국 치킨집과 맥도날드 매장수 (0) | 2015.04.30 |
|---|---|
| 미국 대학생들의 정신질환이 늘어나고 있다 (0) | 2015.04.29 |
| 애플, Apple 실적발표 (0) | 2015.04.29 |
| 2015년 3월 한국 고용동향, 실업률 (0) | 2015.04.27 |
| 한국 실업률은 왜 낮은가 (0) | 2015.04.27 |
